首页 | 本学科首页   官方微博 | 高级检索  
检索        

动态增强磁共振成像对直肠癌术前新辅助治疗疗效的评价
引用本文:周妮娜,陈敏,王文超,赵伟峰,杨正汉,李飒英,张晨.动态增强磁共振成像对直肠癌术前新辅助治疗疗效的评价[J].磁共振成像,2010,1(2):103-109.
作者姓名:周妮娜  陈敏  王文超  赵伟峰  杨正汉  李飒英  张晨
作者单位:卫生部北京医院放射科,100730
摘    要:目的观察动态增强磁共振(DCE—MRI)能否在术前判断直肠癌新辅助治疗的疗效,比较常规T2WI与DCE—MRI对直肠癌术前T、N分期的准确性。方法收集术前或术后病理确诊的直肠癌患者40例。其中行术前新辅助治疗者22例,未进行术前新辅助治疗者18例。所有患者均在GE1.5T Twinspeed HD MR扫描仪行盆腔动态增强扫描。扫描序列包括T2WI压脂、T1WI、DWI,快速三维容积T1加权脂肪抑制成像增强扫描(3DLAVA)。分析动态增强瞌线的各项参数在新辅助治疗前后的变化,观察癌灶曲线上升速率。结果①对未进行术前治疗的直肠癌分期的准确性:DCE—MRI与常规T2WI对直肠癌T分期的准确性分别为83-3%和66.7%,对环周切缘阴性判断准确性为88-2%和70.6%。T2WI及DCE—MRI均能发现直径≥2mm的淋巴结。②对新辅助治疗后直肠癌再分期的准确性:DCE—MRI对T、N再分期的准确性可达86.4%:和81.8%,对环周切缘情况判断准确性为100%。而T2WI进行T、N再分期较困难。③治疗前癌灶的曲线上升速率明显高于正常肠管;治疗后达病理完全缓解组原癌灶部略低于下段正常肠管,但是差异不明显;治疗后未达病理完全缓解组癌灶部仍高于下段正常肠管。结论DCE—MRI对术前直肠癌分期的准确性高,并能够准确判断新辅助治疗后痛周切缘情况。癌灶与参照肠管的上升速率比较有助于在术前判断疗效。

关 键 词:直肠肿瘤  磁共振成像,动态增强  肿瘤辅助疗法  肿瘤分期

Effects of neoadjuvant chemoradiotherapy prior to surgery on rectal cancer assessing by DCE-MRI
ZHOU Ni-na,CHEN Min,WANG Wen-chao,ZHAO Wei-feng,YANG Zheng-han,LI Sa-ying,ZHANG Chen.Effects of neoadjuvant chemoradiotherapy prior to surgery on rectal cancer assessing by DCE-MRI[J].Chinese Journal of Magnetic Resonance Imaging,2010,1(2):103-109.
Authors:ZHOU Ni-na  CHEN Min  WANG Wen-chao  ZHAO Wei-feng  YANG Zheng-han  LI Sa-ying  ZHANG Chen
Institution:(Department of Radiology, Beijing Hospital, Beijing 100730, China)
Abstract:Objective: To evaluate dynamic contrast-enhanced MR imaging (DCE- MRI) in assessing pathologic responses in rectal cancer treated with neoadjuvant chemoradiotherapy (NCRT), and to compare the diagnostic accuracy of T2WI and DCE-MRI in the preoperative T and N staging of rectal cancer. Materials and Methods: Forty patients with pathologically proven primary rectal cancer were enrolled in this study, 18 patients had no preoperative treatments, 22 patients treated with NCRT. DCE-MRI was performed in all patients on GE 1.5 T Twinspeed HD MR scanner. The rectal cancer stage was made according to the TNM classification criteria. Preoperative MRI assessment was compared with postoperative histopathological findings. Parameters of DCE-MRI curves including type of enhancement, the time of maximum uptake, the uptake velocity T, were analyzed. The normal rectum part was selected as control. Results: (1) For rectal cancer without NCRT, DCE-MRI had an accuracy of 83.3% for T staging, and T2WI had an accuracy of 66.7%. For predicting a clear circumferential resection margin (CRM), DCE-MRI had an accuracy of 88.2%, and T2WI had an accuracy of 70.7%. Lymph nodes of diameter more than 2 mm could be found in DCE-MRI and T2WI. (2) For rectal cancer treated with NCRT, DCE-MRI had an accuracy of 86.4% for T staging and 81.8% for N staging in preoperative tumor restaging, and had an accuracy of 100% for predicting a clear CRM. However, T2WI could not distinguish stages for the tumor. (3) The T value of the lesions was equal to or lower than the normal rectum part in pathologic complete response (PCR) group, while the T value of the lesions was higher than normal rectum part in non-PCR group. Conclusion: DCE-MRI has high accuracy for preoperative tumor restaging, and play an important role for predicting circumferential resection margin status of rectal cancer treated with NCRT.
Keywords:Rectal neoplasms  Magnetic resonance imaging  dynamic contrast- enhanced  Neoadjuvant therapy  Neoplasm staging
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号